Study points to ITGb1 as a new antiviral factor in PEDV

A new study suggests integrin beta 1, or ITGb1, does more than help cells stick to their surroundings. Researchers found the cell-surface protein can actively suppress porcine epidemic diarrhea virus, or PEDV, replication by strengthening the pig cell’s innate antiviral response. In cell-based experiments, PEDV infection increased ITGb1 expression, and higher ITGb1 levels reduced viral replication, while loss of ITGb1 increased viral growth and weakened type I interferon signaling. Mechanistically, the team reports that ITGb1 interacts with the viral RNA sensor MDA5, promoting its oligomerization and downstream activation of IRF3, NF-κB, and interferon-beta pathways. The paper was published in late 2025 and positions ITGb1 as a previously unrecognized antiviral host factor in PEDV infection. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals in swine practice, the finding adds to a growing body of work showing that host-side innate immune pathways may be as important as viral targets in PEDV control. That matters because PEDV remains a high-consequence enteric coronavirus in piglets, and there are still no clearly established PEDV-resistant pig lines. Recent industry-backed review work has noted that host genetic resistance remains poorly defined, with current research pointing instead toward immune-response pathways and interferon-related traits as more realistic near-term avenues for intervention. (pmc.ncbi.nlm.nih.gov)

What to watch: The next question is whether ITGb1’s antiviral effect can be validated in pigs, not just cell lines, and whether it can be translated into breeding, immunomodulatory, or therapeutic strategies against PEDV. (pmc.ncbi.nlm.nih.gov)